BlackRock Health Sciences Trust (BME) vs Evercore Inc. (EVR)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| BME | EVR | |
|---|---|---|
| Sector | Financial Services | Financial Services |
| Industry | Asset Management | Capital Markets |
| Size band | SMALL | MID |
| Listing | NYSE | NYSE |
| Country | United States | United States |
| Theme | asset-management | investment-banking |
| Price and returns | ||
| Last close | $45.21 | $257.40 |
| Return · 1 week | +2.05% | +3.81% |
| Return · 1 month | +1.30% | −1.61% |
| Return · 3 months | +3.05% | −24.41% |
| Return · year to date | +13.36% | −26.53% |
| Return · 1 year | +23.05% | −21.66% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −2.63% | −33.78% |
| 52-week high | $46.43 | $388.71 |
| 52-week low | $37.51 | $245.47 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $584.30M | $9.90B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $1.84M | $130.89M |
| Employees | — | 2,715 |
| Valuation | ||
| Price to earnings · trailing | 5.46× | 14.31× |
| Price to earnings · forward | — | 12.20× |
| Price to sales | 74.98× | 2.07× |
| Price to book | 1.00× | 5.26× |
| Enterprise value to revenue | 75.08× | 2.11× |
| PEG ratio | — | 1.15 |
| Earnings per share · trailing | 8.06 | 17.76 |
| Profitability | ||
| Operating margin | 25.43% | 17.83% |
| Profit margin | 1371.16% | 15.82% |
| Return on equity | 19.27% | 39.50% |
| Return on assets | 0.20% | 19.29% |
| Growth | ||
| Revenue growth | −3.80% | +18.80% |
| Earnings growth | — | −1.70% |
| Balance sheet and payout | ||
| Debt / equity (%) | 0.12 | 50.18 |
| Current ratio | 0.81 | 1.83 |
| Dividend yield | 7.15% | 1.40% |
| Payout ratio | 39.02% | 19.20% |
| Trend and volatility | ||
| RSI · 14 | 56.76 | 44.44 |
| ADX · 14 | 16.96 | 30.76 |
| 50-day average | $44.75 | $272.76 |
| 200-day average | $41.98 | $317.53 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 1.68% | 3.54% |
The full BME analysis
Everything this table leaves out for BlackRock Health Sciences Trust: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BME argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BME analysisThe full EVR analysis
Everything this table leaves out for Evercore Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the EVR argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full EVR analysis